Karsdal, M. A., Bay-Jensen, A.-C., Bihlet, A. R., Kraus, V. B., Byrjalsen, I., & Andersen, J. R. (2018). Osteoarthritis clinical trial design and food and drug administration accelerated approval: lessons learned from the osteoporosis and liver fibrosis fields. In Osteoarthritis and Cartilage (Vol. 26, pp. S271–S271). Elsevier BV. https://doi.org/10.1016/j.joca.2018.02.551

Karsdal, M. A., A. -. C. Bay-Jensen, A. R. Bihlet, V. B. Kraus, I. Byrjalsen, and J. R. Andersen. “Osteoarthritis clinical trial design and food and drug administration accelerated approval: lessons learned from the osteoporosis and liver fibrosis fields.” In Osteoarthritis and Cartilage, 26:S271–S271. Elsevier BV, 2018. https://doi.org/10.1016/j.joca.2018.02.551.

Karsdal MA, Bay-Jensen A-C, Bihlet AR, Kraus VB, Byrjalsen I, Andersen JR. Osteoarthritis clinical trial design and food and drug administration accelerated approval: lessons learned from the osteoporosis and liver fibrosis fields. In: Osteoarthritis and Cartilage. Elsevier BV; 2018. p. S271–S271.

Karsdal, M. A., et al. “Osteoarthritis clinical trial design and food and drug administration accelerated approval: lessons learned from the osteoporosis and liver fibrosis fields.” Osteoarthritis and Cartilage, vol. 26, Elsevier BV, 2018, pp. S271–S271. Crossref, doi:10.1016/j.joca.2018.02.551.

Karsdal MA, Bay-Jensen A-C, Bihlet AR, Kraus VB, Byrjalsen I, Andersen JR. Osteoarthritis clinical trial design and food and drug administration accelerated approval: lessons learned from the osteoporosis and liver fibrosis fields. Osteoarthritis and Cartilage. Elsevier BV; 2018. p. S271–S271.